Alcresta Therapeutics, Inc.
USPTO PatentsView assignee record - 22 granted patents across 12 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A23L (Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof).
The verdict
According to USPTO PatentsView, Alcresta ranks #13,291 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 12 technology areas.
- #13,291
- of 49,997 US assignees by volume
- Top 19%
- by Innovation Score (47.4/100)
- 23.1
- avg claims per patent
- +240%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R13291 · US Corporation #13,291 · 22 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 22 grants
- MID-PACK #13,291/49,997
- PHOTO-FINISH ACell
- CPC-FOCUS A23L · 12 areas
- INNOV-PAR 47.4/100
- CLAIMS-DENSE 23.1 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +240% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: ACell, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Alcresta’s 47.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Alcresta
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Alcresta Therapeutics · this assignee
Alcresta Therapeutics · this assignee
47 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Alcresta's Innovation Score is 47.4/100 (top 19% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Alcresta?
Each dot is one of Alcresta’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Alcresta’s own 23.1 claims/patent is ABOVE the 18.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Alcresta's grants concentrate
Alcresta Therapeutics, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 90.9% of grants classified under A23L (Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof). Peak complete grant year is 2024 (9 grants) versus a trough of 1 in 2019. By volume, Alcresta sits between ACell, Inc. and Andes Technology Corporation.
Alcresta's three-year grant acceleration
Alcresta Therapeutics, Inc. shows 11 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Alcresta's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Acell
ACell, Inc.
22 patents
- ADC Therapeutics
ADC Therapeutics SA
22 patents
- Advanpack Solutio…
Advanpack Solutions PTE Ltd.
22 patents
- Albany Molecular…
Albany Molecular Research, Inc.
22 patents
- Alcyone Lifescien…
Alcyone Lifesciences, Inc.
22 patents
- American Maid Pla…
American Maid Plastic Co.
22 patents
- Amerlux
Amerlux, LLC
22 patents
- Andes Technology
Andes Technology Corporation
22 patents
- Alcresta Therapeu… ◀
Alcresta Therapeutics, Inc.
22 patents
What this shows Alcresta holds 22 patents at rank #13,282, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Alcresta
By rank, the assignees closest to #13,282 in granted patent volume.
- ACell, Inc. #13,278 · 22 patents
- ADC Therapeutics SA #13,279 · 22 patents
- Advanpack Solutions PTE Ltd. #13,280 · 22 patents
- Albany Molecular Research, Inc. #13,281 · 22 patents
- Alcyone Lifesciences, Inc. #13,283 · 22 patents
- American Maid Plastic Co. #13,284 · 22 patents
- Amerlux, LLC #13,285 · 22 patents
- Andes Technology Corporation #13,286 · 22 patents
Leaders in A23L (Foods)
Other assignees with the most granted patents in Alcresta's primary technology class.
Alcresta's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
47 Top 19% higher than 81% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 4 | 18.2% |
| 2019 | 1 | 4.5% |
| 2020 | 3 | 13.6% |
| 2021 | 3 | 13.6% |
| 2022 | 2 | 9.1% |
| 2024 | 9 | 40.9% |
Which technologies does Alcresta Therapeutics, Inc. patent most?
Top 12 of 12 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Alcresta Therapeutics, Inc.'s patent record in context - here's where to go next.
- Alcresta Therapeutics, Inc.'s lead technology class is A23L (Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof), 90.9% of its portfolio - see every assignee active in that class. Explore A23L
- Ranked #13,291 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Alcresta Therapeutics, Inc. against ACell, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 47.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.